Board Changes (3265L)

TIDMATD

RNS Number : 3265L

Asterand PLC

29 July 2011

 
 For Immediate Release   29 July 2011

Asterand plc

("Asterand" or the "Company")

Board Changes

The Company today announces that Martyn Coombs has decided to step down as Chief Executive Officer, with immediate effect.

Martyn has been responsible for guiding the Company though an exciting period in its development, including the acquisition of BioSeek in 2010 which has added significantly to the Company's growth prospects.

The Company has immediately commissioned a search process for the new CEO. In the meantime Jack Davis, the Company's Chairman, will take over the role of Interim CEO.

Jack Davis, the Chairman and Interim CEO, said: "Martyn has been a positive influence as CEO over the last four years and we wish him well for the future."

The Company continues to experience the trading patterns described in the IMS on 17 May 2011 and, not withstanding the historical weighting towards the second half, the Board remains confident in achieving market expectations for the year as a whole.

Contacts:

 
 Asterand plc 
 Jack Davis, Chairman and Interim Chief   Tel: + 44 (0) 1763 211 600 / + 
  Executive Officer                        1 (313) 263-0960 
 John Stchur, Chief Financial Officer     As above 
 
 Buchanan Communications 
 Lisa Baderoon / Mark Court / Isabel      Tel: +44 (0) 20 7466 5000 
  Podda 
 
 Daniel Stewart & Company plc 
 Antony Legge                             Tel: +44 (0) 20 7776 6550 
 Martin Lampshire

About Asterand

Asterand plc is a leading supplier of high quality human tissue and tissue-based services. Our comprehensive approach to human tissue and research services offers pharmaceutical, biotech and diagnostic companies the unique opportunity to have one company meet all of their human biomaterial needs along the continuum of drug discovery and development. Our mission is to accelerate target discovery and compound validation and enable pharmaceutical and biotechnology companies to take safer and more effective drugs into the market. For more information about Asterand, go to www.asterand.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

BOABVLLLFDFFBBQ

Bioseek (LSE:ATD)
Historical Stock Chart
From Jun 2024 to Jul 2024